David Mack/Photo Researchers, Inc. Since 1998, when 18-year-old Jesse Gelsinger died in a clinical trial at the University of Pennsylvania, the news on gene therapy hasn't gotten much better. In a ...
Hosted on MSN1mon
UPenn gene therapy pioneer’s biotech gets $34 million in fundingHe became widely known as the lead scientist in a gene therapy trial that led to the 1999 death of 18-year-old Jesse Gelsinger, the first person to die as a result of gene therapy. The tragedy led ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback